Heart disease remains the leading cause of death in the United States and other developed countries. Half of these deaths occur suddenly, typically from ventricular tachyarrhythmias that arise in the setting of acute ischemia, acquired heart disease or inherited syndromes including channelopathies and cardiomyopathies. Gap junction channels are responsible for normal impulse propagation and gap junction remodeling contributes to these lethal rhythm disturbances. A detailed understanding of the mechanisms responsible for gap junction remodeling are lacking, preventing the development of anti-arrhythmic strategies targeting the gap junction protein complex. Through the use of genetically engineered mice and novel high throughput genetic screens, we propose a series of experiments to more fully characterize the molecular mechanisms responsible for gap junction remodeling, with the longer term goal of identifying novel therapeutics.

Public Health Relevance

Heart disease is the leading cause of death in the United States and other developed countries and almost half of these deaths occur suddenly from heart rhythm abnormalities. Our research is directed toward understanding the mechanisms responsible for these lethal arrhythmias and identifying potential new therapeutic targets.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Electrical Signaling, Ion Transport, and Arrhythmias Study Section (ESTA)
Program Officer
Krull, Holly
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Park, David S; Shekhar, Akshay; Marra, Christopher et al. (2016) Fhf2 gene deletion causes temperature-sensitive cardiac conduction failure. Nat Commun 7:12966
Park, David S; Fishman, Glenn I (2014) Nav-igating through a complex landscape: SCN10A and cardiac conduction. J Clin Invest 124:1460-2
Kim, Eugene; Fishman, Glenn I (2013) Designer gap junctions that prevent cardiac arrhythmias. Trends Cardiovasc Med 23:33-8
Stewart, Michael K G; Gong, Xiang-Qun; Barr, Kevin J et al. (2013) The severity of mammary gland developmental defects is linked to the overall functional status of Cx43 as revealed by genetically modified mice. Biochem J 449:401-13
Danielson, Laura S; Park, David S; Rotllan, Noemi et al. (2013) Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J 27:1460-7
Remo, Benjamin F; Giovannone, Steven; Fishman, Glenn I (2012) Connexin43 cardiac gap junction remodeling: lessons from genetically engineered murine models. J Membr Biol 245:275-81
Lorentz, R; Shao, Q; Huang, T et al. (2012) Characterization of gap junction proteins in the bladder of Cx43 mutant mouse models of oculodentodigital dysplasia. J Membr Biol 245:345-55
Park, David S; Fishman, Glenn I (2012) Forever young: induced pluripotent stem cells as models of inherited arrhythmias. Circulation 125:3055-6
Giovannone, Steven; Remo, Benjamin F; Fishman, Glenn I (2012) Channeling diversity: gap junction expression in the heart. Heart Rhythm 9:1159-62
Remo, Benjamin F; Qu, Jiaxiang; Volpicelli, Frank M et al. (2011) Phosphatase-resistant gap junctions inhibit pathological remodeling and prevent arrhythmias. Circ Res 108:1459-66

Showing the most recent 10 out of 24 publications